Europe’s medicines regulator found a possible link between the coronavirus vaccine developed by AstraZeneca and the University of Oxford and rare blood clotting issues — though it said the benefits of getting the shot still outweigh its risks. Unusual blood clotting with low blood platelets will be added as a “very rare” side effect to the vaccine’s […] Read more